Periodic Reporting for period 3 - ChiCC (Chirality via Cross-Coupling: New Asymmetric C-C Bond Formations Driven by Atom and Step Economy)

Over 60% of the world’s top selling small molecule drug compounds are chiral and, of these, approximately 80% are marketed as single enantiomers. Surprisingly, and despite the tremendous advances made in catalysis over the past several decades, the average “chiral...